Misbah SA - Search Results

1

An approach to the diagnosis and management of systemic vasculitis.

Miller A, Chan M, Wiik A, Misbah SA, Luqmani RA. Miller A, et al. Among authors: misbah sa. Clin Exp Immunol. 2010 May;160(2):143-60. doi: 10.1111/j.1365-2249.2009.04078.x. Epub 2010 Jan 12. Clin Exp Immunol. 2010. PMID: 20070316 Free PMC article. Review.

2

Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.

Arnold DF, Timms A, Luqmani R, Misbah SA. Arnold DF, et al. Among authors: misbah sa. J Clin Pathol. 2010 Aug;63(8):678-80. doi: 10.1136/jcp.2009.072504. J Clin Pathol. 2010. PMID: 20702467

3

Is rheumatoid factor useful in primary care? A retrospective cross-sectional study.

Miller A, Mahtani KR, Waterfield MA, Timms A, Misbah SA, Luqmani RA. Miller A, et al. Among authors: misbah sa. Clin Rheumatol. 2013 Jul;32(7):1089-93. doi: 10.1007/s10067-013-2236-0. Epub 2013 Mar 21. Clin Rheumatol. 2013. PMID: 23515604

4

Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Misbah SA. Misbah SA. Clin Exp Immunol. 2017 Jun;188(3):342-352. doi: 10.1111/cei.12948. Epub 2017 Mar 27. Clin Exp Immunol. 2017. PMID: 28245526 Free PMC article. Review.

5

Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials.

Ballow M, Wasserman RL, Jolles S, Chapel H, Berger M, Misbah SA. Ballow M, et al. Among authors: misbah sa. J Clin Immunol. 2017 Aug;37(6):517-518. doi: 10.1007/s10875-017-0410-x. Epub 2017 Jul 10. J Clin Immunol. 2017. PMID: 28695366 Free PMC article. No abstract available.

6

Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?

Dhalla F, Lucas M, Schuh A, Bhole M, Jain R, Patel SY, Misbah S, Chapel H. Dhalla F, et al. J Clin Immunol. 2014 Apr;34(3):277-82. doi: 10.1007/s10875-014-9995-5. Epub 2014 Feb 21. J Clin Immunol. 2014. PMID: 24557494 Review.

7

Effective dosing strategies for therapeutic immunoglobulin: managing wear-off effects in antibody replacement to immunomodulation.

Misbah SA. Misbah SA. Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):70-1. doi: 10.1111/cei.12517. Clin Exp Immunol. 2014. PMID: 25546768 Free PMC article. No abstract available.

8

Subcutaneous immunoglobulin: opportunities and outlook.

Misbah S, Sturzenegger MH, Borte M, Shapiro RS, Wasserman RL, Berger M, Ochs HD. Misbah S, et al. Clin Exp Immunol. 2009 Dec;158 Suppl 1(Suppl 1):51-9. doi: 10.1111/j.1365-2249.2009.04027.x. Clin Exp Immunol. 2009. PMID: 19883424 Free PMC article. Review.

9

Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.

Aslam A, Newman TL, Misbah SA. Aslam A, et al. Among authors: misbah sa. J Clin Pathol. 2003 Oct;56(10):775-7. doi: 10.1136/jcp.56.10.775. J Clin Pathol. 2003. PMID: 14514783 Free PMC article.

10

Bringing immunoglobulin knowledge up to date: how should we treat today?

Misbah S, Kuijpers T, van der Heijden J, Grimbacher B, Guzman D, Orange J. Misbah S, et al. Clin Exp Immunol. 2011 Oct;166(1):16-25. doi: 10.1111/j.1365-2249.2011.04443.x. Epub 2011 Jul 15. Clin Exp Immunol. 2011. PMID: 21762127 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters